Cargando…
The multi-target small-molecule inhibitor SB747651A shows in vitro and in vivo anticancer efficacy in glioblastomas
Glioblastoma multiforme is the most common primary brain tumor and among the most lethal types of cancer. Several mono-target small molecule-inhibitors have been investigated as novel therapeutics, thus far with poor success. In this study we investigated the anticancer effects of SB747651A, a multi...
Autores principales: | Knudsen, Arnon Møldrup, Boldt, Henning Bünsow, Jakobsen, Elisabeth Victoria, Kristensen, Bjarne Winther |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7966768/ https://www.ncbi.nlm.nih.gov/pubmed/33727611 http://dx.doi.org/10.1038/s41598-021-85536-4 |
Ejemplares similares
-
Expression and prognostic value of the transcription factors EGR1 and EGR3 in gliomas
por: Knudsen, Arnon Møldrup, et al.
Publicado: (2020) -
The Specific Mitogen- and Stress-Activated Protein Kinase MSK1 Inhibitor SB-747651A Modulates Chemokine-Induced Neutrophil Recruitment
por: Hossain, Mokarram, et al.
Publicado: (2017) -
Surgical resection of glioblastomas induces pleiotrophin-mediated self-renewal of glioblastoma stem cells in recurrent tumors
por: Knudsen, Arnon Møldrup, et al.
Publicado: (2021) -
AN1-type zinc finger protein 3 (ZFAND3) is a transcriptional regulator that drives Glioblastoma invasion
por: Schuster, Anne, et al.
Publicado: (2020) -
Factors determining the density of AQP4 water channel molecules at the brain–blood interface
por: Hoddevik, Eystein Hellstrøm, et al.
Publicado: (2016)